Urodynamic results, clinical efficacy, and complication rates of sacral intradural deafferentation and sacral anterior root stimulation in patients with neurogenic lower urinary tract dysfunction resulting from complete spinal cord injury

Neurourol Urodyn. 2014 Nov;33(8):1202-6. doi: 10.1002/nau.22486. Epub 2013 Sep 4.

Abstract

Aims: To investigate the outcome and complications of sacral deafferentation (SDAF) and sacral anterior root stimulation (SARS) in patients with neurogenic lower urinary tract dysfunction (NLUTD) resulting from complete spinal cord injury (SCI).

Methods: Retrospective chart analysis of 137 patients who underwent SDAF/SARS at a single institution. Patients were categorized as being at risk of renal damage when the maximum detrusor pressure was >40 cmH2 O or detrusor compliance was <20 ml/cmH2 O.

Results: After a mean follow-up time of 14.8 ± 5.3 years, SDAF/SARS treatment significantly (P < 0.001) reduced the number of patients suffering from elevated detrusor pressure from 65 to 2, and from low detrusor compliance from 62 to 13, respectively. Mean bladder capacity significantly (P < 0.001) improved from 272.4 ± 143.0 to 475.0 ± 82.7 ml. The mean number of symptomatic UTI also decreased significantly (P < 0.001) from 6.2 ± 4.5 to 2.5 ± 2.6 per year. The number of patients suffering from incontinence had significantly (P < 0.001) decreased from 70 to 44. At the last follow-up visit, 107 (78.1%) patients were still using the stimulator. A total of 84 complications requiring surgical revision were observed. Defects of the stimulator cables or the receiver plate were the most common events (n = 38). The retrospective design pertains to the limitations of the study.

Conclusions: Sacral deafferentation and SARS are an effective treatment option for refractory NLUTD in patients with complete SCI, despite a substantial long-term complication rate.

Keywords: Brindley stimulator; neurogenic bladder dysfunction; sacral deafferentation and anterior root stimulation; spinal cord injury; urodynamics.

MeSH terms

  • Adult
  • Afferent Pathways
  • Electric Stimulation Therapy* / adverse effects
  • Female
  • Humans
  • Implantable Neurostimulators*
  • Male
  • Retrospective Studies
  • Spinal Cord Injuries / complications
  • Spinal Nerve Roots
  • Treatment Outcome
  • Urinary Bladder, Neurogenic / etiology
  • Urinary Bladder, Neurogenic / physiopathology*
  • Urinary Bladder, Neurogenic / therapy*
  • Urodynamics*